Literature DB >> 16623717

Local binding with globally distributed changes in a small protease inhibitor upon enzyme binding.

Zoltán Gáspári1, Borbála Szenthe, András Patthy, William M Westler, László Gráf, András Perczel.   

Abstract

Complexation of the small serine protease inhibitor Schistocerca gregaria chymotrypsin inhibitor (SGCI), a member of the pacifastin inhibitor family, with bovine chymotrypsin was followed by NMR spectroscopy. (1)H-(15)N correlation (HSQC) spectra of the inhibitor with increasing amounts of the enzyme reveal tight and specific binding in agreement with biochemical data. Unexpectedly, and unparalleled among canonical serine protease inhibitors, not only residues in the protease-binding loop of the inhibitor, but also some segments of it located spatially far from the substrate-binding cleft of the enzyme were affected by complexation. However, besides changes, some of the dynamical features of the free inhibitor are retained in the complex. Comparison of the free and complexed inhibitor structures revealed that most, but not all, of the observed chemical shift changes can be attributed to minor structural transitions. We suggest that the classical 'scaffold + binding loop' model of canonical inhibitors might not be fully valid for the inhibitor family studied. In our view, this feature allows for the emergence of both taxon-specific and nontaxon-specific inhibitors in this group of small proteins.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16623717     DOI: 10.1111/j.1742-4658.2006.05204.x

Source DB:  PubMed          Journal:  FEBS J        ISSN: 1742-464X            Impact factor:   5.542


  1 in total

1.  High affinity small protein inhibitors of human chymotrypsin C (CTRC) selected by phage display reveal unusual preference for P4' acidic residues.

Authors:  András Szabó; Dávid Héja; Dávid Szakács; Katalin Zboray; Katalin A Kékesi; Evette S Radisky; Miklós Sahin-Tóth; Gábor Pál
Journal:  J Biol Chem       Date:  2011-04-22       Impact factor: 5.157

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.